Skip to content

Firm News

5 Reasons Why Equity-Based Crowdfunding Under the JOBS Act Won’t Work

February 25, 2013

5 Reasons Why Equity-Based Crowdfunding Under the JOBS Act Won’t Work

February 25, 2013

Towerstream Corporation

January 28, 2013

Northwest Biotherapeutics, Inc.

December 28, 2012

Jeffrey Fessler Attends the NASDAQ Opening Bell Ringing with Northwest Biotherapeutics, Inc. (NWBO)

December 20, 2012

Jeffrey Fessler Attends the NASDAQ Opening Bell Ringing with Northwest Biotherapeutics, Inc. (NWBO)

December 20, 2012

SICHENZIA ROSS FRIEDMAN FERENCE LLP Welcomes Bankruptcy Partner Ralph E. Preite

November 16, 2012

Hurricane Sandy Update

November 5, 2012

Hurricane Sandy Update

November 5, 2012

Pure Biosciences, Inc.

September 28, 2012

Sichenzia Ross Friedman Ference LLP Welcomes Jay M. Kaplowitz and Arthur S. Marcus Formerly of Gersten Savage

September 18, 2012

Sichenzia Ross Friedman Ference LLP Welcomes Jay M. Kaplowitz and Arthur S. Marcus Formerly of Gersten Savage

September 18, 2012

ARCA Biopharma, Inc.

August 28, 2012

Practical Considerations In Finding The Right Athlete to Endorse Your Prodcuts

August 17, 2012

Sichenzia Ross Friedman Ference LLP Advises Ladenburg Thalmann & Co. Inc. on $1 Million Secondary Public Offering for Arca Biopharma, Inc.

August 2, 2012

Ampio Pharmaceuticals, Inc.

July 28, 2012

Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp on $17.5 million Secondary Public Offering for Ampio Pharmaceuticals, Inc.

July 12, 2012

Meyers Associates

June 28, 2012

The Times They Are A-Changin’: What does the JOBS Act mean for theater and film producers?

June 26, 2012

Sichenzia Ross Friedman Ference LLP Launches New Website

June 20, 2012

Sichenzia Ross Friedman Ference LLP Advises Trovagene, Inc. on $10.58 Million Public Offering

June 4, 2012